Status:
COMPLETED
Promoting Adolescent Investment In Diabetes Care
Lead Sponsor:
Harvard Pilgrim Health Care
Collaborating Sponsors:
Seattle Children's Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
Two financial incentive strategies targeting adolescents with type 1 diabetes will be compared to usual care for motivating adolescents to engage in improved self-care to manage their diabetes.
Detailed Description
Participants will be asked to choose a self-care goal relevant to the device(s) they use to manage their diabetes from a pre-defined list of self-care targets. A randomized 3 (treatment) x 3 (occasion...
Eligibility Criteria
Inclusion
- \>12 and ≤18 years old
- Diagnosed with type 1 diabetes ≥12 months
- Speaks English fluently
- Cognitively able to participate in incentive program and complete surveys.
- Have access to a mobile phone to receive goal-obtainment and incentive updates
- Receives diabetes-related clinical care from Seattle Children's Hospital Diabetes Clinic
- Have the ability to upload medical data remotely from home per usual care processes employed by Seattle Children's Hospital Diabetes Clinics
Exclusion
- Patient is already participating in another research study to improve diabetes self-care and/or glycemic control
- Baseline daily average glucose checks are greater than 4 checks per day OR baseline daily CGM active wear is greater than 70% of the time AND baseline average insulin bolus score is greater than 3 times a day OR they do not use an insulin pump (or are unwilling to use a smart insulin pen)
- Patient refusal to participate (any age), or caregiver refusal to participate for patients less than 18 years of age
- Cognitively or physically unable to participate
- Patient is unable to speak in the English language
- Patient is unable to read in the English language
- Patient is a ward of the state
- Patient has severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
Key Trial Info
Start Date :
September 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2022
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04516694
Start Date
September 10 2020
End Date
January 8 2022
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Children's Research Institute
Seattle, Washington, United States, 98121